IDEAS home Printed from https://ideas.repec.org/a/pal/joibpo/v3y2020i4d10.1057_s42214-020-00070-w.html
   My bibliography  Save this article

Pharmaceutical patent examination outcomes in the Dominican Republic

Author

Listed:
  • Luis Gil Abinader

    (University of Buenos Aires)

Abstract

In the Dominican Republic, the legal provisions requiring the substantive examination of patent applications were enacted 20 years ago, along with the implementation of the TRIPS agreement. Prior to this, the country had a registration system in which all applications that were filed ended up being registered. This offers an opportunity to explore the outcomes of applications in a country that embarked on substantive patent examinations relatively recently. and which has drawn comparatively less attention in academic research related to the rigorousness of patentability criteria. Based on a novel dataset of pharmaceutical patent applications filed in the Dominican Republic between 2000 and 2015, I find that only 16% of them were granted. This seems surprisingly low. However, I also find that grant rates may be influenced by several factors, including some that are not strictly related to patent examination. In particular, some applications may have been disposed of without a grant because their applicants acquired additional knowledge, indicating that the underlying inventions lacked commercial value. This calls for more attention towards other policies – such as legal provisions and institutional arrangements designed to accelerate the speed of patent examination – which could also be determinants of grant rates.

Suggested Citation

  • Luis Gil Abinader, 2020. "Pharmaceutical patent examination outcomes in the Dominican Republic," Journal of International Business Policy, Palgrave Macmillan, vol. 3(4), pages 385-407, December.
    • Handle: RePEc:pal:joibpo:v:3:y:2020:i:4:d:10.1057_s42214-020-00070-w
    DOI: 10.1057/s42214-020-00070-w
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1057/s42214-020-00070-w
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1057/s42214-020-00070-w?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Amy Kapczynski & Chan Park & Bhaven Sampat, 2012. "Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-9, December.
    2. Bhaven N Sampat & Kenneth C Shadlen, 2018. "Indian pharmaceutical patent prosecution: The changing role of Section 3(d)," PLOS ONE, Public Library of Science, vol. 13(4), pages 1-19, April.
    3. Sampat, Bhaven N. & Shadlen, Kenneth C., 2017. "Secondary pharmaceutical patenting: A global perspective," Research Policy, Elsevier, vol. 46(3), pages 693-707.
    4. Jean O. Lanjouw & Ariel Pakes & Jonathan Putnam, 1998. "How to Count Patents and Value Intellectual Property: The Uses of Patent Renewal and Application Data," Journal of Industrial Economics, Wiley Blackwell, vol. 46(4), pages 405-432, December.
    5. Shadlen, Kenneth C., 2017. "Coalitions and Compliance: The Political Economy of Pharmaceutical Patents in Latin America," OUP Catalogue, Oxford University Press, number 9780199593903.
    6. María José Abud & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-17, April.
    7. Yamauchi, Isamu & Nagaoka, Sadao, 2015. "An economic analysis of deferred examination system: Evidence from a policy reform in Japan," International Journal of Industrial Organization, Elsevier, vol. 39(C), pages 19-28.
    8. Lanjouw, Jean O & Pakes, Ariel & Putnam, Jonathan, 1998. "How to Count Patents and Value Intellectual Property: The Uses of Patent Renewal and Application Data," Journal of Industrial Economics, Wiley Blackwell, vol. 46(4), pages 405-432, December.
    9. Carlos Correa, 2007. "Guidelines for the Examination of Pharmaceutical Patents: Developing a Public Health Perspective," Working Papers id:1203, eSocialSciences.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sampat, Bhaven N. & Shadlen, Kenneth C., 2017. "Secondary pharmaceutical patenting: A global perspective," Research Policy, Elsevier, vol. 46(3), pages 693-707.
    2. Nadia Ayari & Szabolcs Blazsek & Pedro Mendi, 2012. "Renewable energy innovations in Europe: a dynamic panel data approach," Applied Economics, Taylor & Francis Journals, vol. 44(24), pages 3135-3147, August.
    3. Nicholas Bloom & Tarek Alexander Hassan & Aakash Kalyani & Josh Lerner & Ahmed Tahoun, 2021. "The diffusion of disruptive technologies," CEP Discussion Papers dp1798, Centre for Economic Performance, LSE.
    4. Antoine Dechezleprêtre & Elias Einiö & Ralf Martin & Kieu-Trang Nguyen & John Van Reenen, 2016. "Do tax Incentives for Research Increase Firm Innovation? An RD Design for R&D," NBER Working Papers 22405, National Bureau of Economic Research, Inc.
    5. Guan-Can Yang & Gang Li & Chun-Ya Li & Yun-Hua Zhao & Jing Zhang & Tong Liu & Dar-Zen Chen & Mu-Hsuan Huang, 2015. "Using the comprehensive patent citation network (CPC) to evaluate patent value," Scientometrics, Springer;Akadémiai Kiadó, vol. 105(3), pages 1319-1346, December.
    6. de Rassenfosse, Gaétan, 2013. "Do firms face a trade-off between the quantity and the quality of their inventions?," Research Policy, Elsevier, vol. 42(5), pages 1072-1079.
    7. Schankerman, Mark & Lanjouw, Jean, 2001. "Enforcing Intellectual Property Rights," CEPR Discussion Papers 3093, C.E.P.R. Discussion Papers.
    8. Jianzhuang Zheng & Muhammad Usman Khurram & Lifeng Chen, 2022. "Can Green Innovation Affect ESG Ratings and Financial Performance? Evidence from Chinese GEM Listed Companies," Sustainability, MDPI, vol. 14(14), pages 1-32, July.
    9. Barbieri, Nicolò & Marzucchi, Alberto & Rizzo, Ugo, 2020. "Knowledge sources and impacts on subsequent inventions: Do green technologies differ from non-green ones?," Research Policy, Elsevier, vol. 49(2).
    10. Satoshi Yasukawa & Shingo Kano, 2014. "Validating the usefulness of examiners’ forward citations from the viewpoint of applicants’ self-selection during the patent application procedure," Scientometrics, Springer;Akadémiai Kiadó, vol. 99(3), pages 895-909, June.
    11. Christine MacLeod & Jennifer Tann & James Andrew & Jeremy Stein, 2003. "Evaluating inventive activity: the cost of nineteenth‐century UK patents and the fallibility of renewal data," Economic History Review, Economic History Society, vol. 56(3), pages 537-562, August.
    12. Slottje, Daniel J. & Millimet, Daniel L. & Buchanan, Michael J., 2007. "Econometric analysis of copyrights," Journal of Econometrics, Elsevier, vol. 139(2), pages 303-317, August.
    13. Basir, Nada & Beyhaghi, Mehdi & Mohammadi, Ali, 2014. "The Fate Of Patents: An Exploratory Analysis Of Patents As Ipo Signals Of Reputational Advantage," Working Paper Series in Economics and Institutions of Innovation 348, Royal Institute of Technology, CESIS - Centre of Excellence for Science and Innovation Studies.
    14. Kenneth Zahringer & Christos Kolympiris & Nicholas Kalaitzandonakes, 2018. "Time to patent at the USPTO: the case of emerging entrepreneurial firms," The Journal of Technology Transfer, Springer, vol. 43(4), pages 923-952, August.
    15. Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John Van Reenen, 2016. "Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry," Journal of Political Economy, University of Chicago Press, vol. 124(1), pages 1-51.
    16. Biggi, Gianluca & Giuliani, Elisa & Martinelli, Arianna & Benfenati, Emilio, 2022. "Patent Toxicity," Research Policy, Elsevier, vol. 51(1).
      • Gianluca Biggi & Elisa Giuliani & Arianna Martinelli, 2020. "Patent Toxicity," LEM Papers Series 2020/33, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
    17. Éric Archambault, 2002. "Methods for using patents in cross-country comparisons," Scientometrics, Springer;Akadémiai Kiadó, vol. 54(1), pages 15-30, April.
    18. Dominique Guellec & Bruno Van Pottelsberghe de la Potterie, 2002. "The Value of Patents and Patenting Strategies: Countries and Technology Areas Patterns," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 11(2), pages 133-148.
    19. Patricia Laurens & Christian Le Bas & Antoine Schoen, 2019. "Worldwide IP coverage of patented inventions in large pharma firms: to what extent do the internationalisation of R&D and firm strategy matter?," Post-Print hal-01725229, HAL.
    20. Caviggioli, Federico & De Marco, Antonio & Montobbio, Fabio & Ughetto, Elisa, 2020. "The licensing and selling of inventions by US universities," Technological Forecasting and Social Change, Elsevier, vol. 159(C).

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:joibpo:v:3:y:2020:i:4:d:10.1057_s42214-020-00070-w. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.palgrave.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.